Almquist R G, Chao W R, Ellis M E, Johnson H L
J Med Chem. 1980 Dec;23(12):1392-8. doi: 10.1021/jm00186a020.
An analogue of a tripeptide inhibitor of angiotensin converting enzyme, Bz-Phe-Gly-Pro, has been synthesized in which the amide bond connecting phenylalanine and glycine has been replaced by a ketomethylene group. This nonpeptide analogue, 20, shows more potent converting enzyme inhibiting activity, I50 = 0.07 microM, than Bz-Phe-Gly-Pro, I50 = 9.4 microM, or than the orally active D-3-mercapto-2-methylpropanoyl-L-proline (captopril, 1), I50 = 0.30 microM. Compound 20 has a Ki of 1.06 X 10(-7) and either competitive or noncompetitive enzyme kinetics depending on what substrate is used in the converting enzyme assay. In tests for inhibition of angiotensin I induced contractions in the guinea pig ileum, 20 has one-tenth the activity of 1.
已合成血管紧张素转换酶三肽抑制剂Bz-Phe-Gly-Pro的类似物,其中连接苯丙氨酸和甘氨酸的酰胺键已被酮亚甲基取代。这种非肽类似物20显示出比Bz-Phe-Gly-Pro(I50 = 9.4 microM)或口服活性的D-3-巯基-2-甲基丙酰-L-脯氨酸(卡托普利,1,I50 = 0.30 microM)更强的转换酶抑制活性,I50 = 0.07 microM。化合物20的Ki为1.06×10^(-7),根据在转换酶测定中使用的底物不同,其酶动力学表现为竞争性或非竞争性。在豚鼠回肠中抑制血管紧张素I诱导的收缩试验中,20的活性是1的十分之一。